Bayer Menopause Drug Lands FDA Approval, Bringing Competition to an Astellas Product
Bayer’s Lynkuet, approved for treating moderate-to-severe vasomotor symptoms of menopause, targets two receptors key to temperature regulation. The once-daily pill came from Bayer’s 2020 acquisition of KaNDy Therapeutics.
Innovations Offer Hope in the Fight Against Antibiotic Resistance
Antibiotic resistance is a growing global threat with serious health and economic consequences. Yet there is progress – from rapid PCR diagnostics and AI-driven research to new drug development and innovative funding models.
Phony Bank Account Change Requests: A Growing Threat for Healthcare Finance Leaders
Phony bank account change requests aren’t just another check box on a fraud prevention list – they’re one of the most immediate and dangerous threats facing healthcare AP teams today.
presented by
Hancock Health’s $1.1M Turnaround
Facing a loss of patients and revenue to outside referrals, Hancock Health joined the Mayo Clinic Care Network and achieved a dramatic turnaround.
How the Stigma Around Male Infertility Can Be Reduced
At the HLTH conference in Las Vegas, Colton Underwood and fertility experts highlighted the need to break the stigma around male infertility, urging greater awareness, testing and support to recognize it as a men’s health issue as much as a women’s one.